BioForce Nanosciences Holdings (BFNH) Income Statement
BioForce Nanosciences Holdings Income Statement
Last quarter (Q2 2026), BioForce Nanosciences Holdings's total revenue was $0.00. In Q2, BioForce Nanosciences Holdings's net income was $238.68K. See BioForce Nanosciences Holdings’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 489.95K | $ 490.44K | $ 471.95K | $ 485.51K | $ 501.95K | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 471.95K | $ 0.00 | $ 0.00 |
| $ -489.95K | $ -490.44K | $ 0.00 | $ -485.51K | $ -501.95K | |
| $ -489.95K | $ -490.44K | $ -471.95K | $ -485.51K | $ -501.95K | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -489.95K | $ -490.44K | $ -471.95K | $ -485.51K | $ -501.95K | |
| $ -1.29M | $ -490.44K | $ -471.95K | $ -485.51K | $ -501.95K | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.04 | $ -0.02 | $ -0.02 | $ -0.02 | $ -0.02 |
| Diluted EPS | $ -0.04 | $ -0.02 | $ -0.02 | $ -0.02 | $ -0.02 |
| Weighted Average Shares Outstanding | 33.21M | 29.27M | 29.27M | 29.27M | 29.27M |
| Weighted Average Shares Outstanding (Diluted) | 33.21M | 29.27M | 29.27M | 29.27M | 29.27M |
Currency in USD
